Literature DB >> 28448697

National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care.

Donovan T Maust1,2, Frederic C Blow2, Ilse R Wiechers3, Helen C Kales2, Steven C Marcus4.   

Abstract

OBJECTIVE: To describe how use of antidepressants, benzodiazepines, and other anxiolytic/sedative-hypnotics among older adults (age ≥ 65 years) has changed over time among visits to primary care providers and psychiatrists.
METHODS: Data were from the National Ambulatory Medical Care Survey (years 2003-2005 and 2010-2012), a nationally representative cross-section of outpatient physician visits. Analysis focused on visits to primary care providers (n = 14,282) and psychiatrists (n = 1,095) at which an antidepressant, benzodiazepine, or other anxiolytic/sedative-hypnotic was prescribed, which were stratified by demographic and clinical characteristic (including ICD-9-CM diagnosis) and compared across study intervals. Odds of medication use were calculated for each stratum, adjusting for demographic and clinical characteristics.
RESULTS: The visit rate by older adults to primary care providers where any of the medications were prescribed rose from 16.4% to 21.8% (adjusted odds ratio [AOR] = 1.43, P < .001) while remaining steady among psychiatrists (75.4% vs 68.5%; AOR = 0.69, P = .11). Primary care visits rose for antidepressants (9.9% to 12.3%; AOR = 1.28, P = .01) and other anxiolytic/sedative-hypnotics (3.4% to 4.7%; AOR = 1.39, P = .01), but the largest growth was among benzodiazepines (5.6% to 8.7%; AOR = 1.62, P < .001). Among patients in primary care, increases primarily occurred among men, non-Hispanic white patients, and those with pain diagnoses as well as those with no mental health or pain diagnoses.
CONCLUSIONS: From 2003 to 2012, use of the most common psychotropic medications among older adults seen in primary care increased, with concentration among patients with no mental health or pain diagnosis. As the population of older adults grows and receives mental health treatment in primary care, it is critical to examine the appropriateness of psychotropic use. © Copyright 2017 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28448697      PMCID: PMC5408458          DOI: 10.4088/JCP.16m10713

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  58 in total

1.  1979 summary: National Ambulatory Medical Care Survey.

Authors:  T McLemore
Journal:  Adv Data       Date:  1981-03-02

2.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

3.  Trends in prescribing of sedative-hypnotic medications in the USA: 1993-2010.

Authors:  Christopher N Kaufmann; Adam P Spira; G Caleb Alexander; Lainie Rutkow; Ramin Mojtabai
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-12-29       Impact factor: 2.890

4.  Antidepressant use in the absence of common mental disorders in the general population.

Authors:  Jina Pagura; Laurence Y Katz; Ramin Mojtabai; Benjamin G Druss; Brian Cox; Jitender Sareen
Journal:  J Clin Psychiatry       Date:  2011-01-25       Impact factor: 4.384

5.  Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use.

Authors:  Colleen M Cunningham; Gillian E Hanley; Steve Morgan
Journal:  Health Policy       Date:  2010-04-21       Impact factor: 2.980

Review 6.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

Review 7.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons.

Authors:  John C Woolcott; Kathryn J Richardson; Matthew O Wiens; Bhavini Patel; Judith Marin; Karim M Khan; Carlo A Marra
Journal:  Arch Intern Med       Date:  2009-11-23

8.  Caring for mental illness in the United States: a focus on older adults.

Authors:  Ruth Klap; Kathleen Tschantz Unroe; Jürgen Unützer
Journal:  Am J Geriatr Psychiatry       Date:  2003 Sep-Oct       Impact factor: 4.105

9.  National patterns in antidepressant medication treatment.

Authors:  Mark Olfson; Steven C Marcus
Journal:  Arch Gen Psychiatry       Date:  2009-08

10.  Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.

Authors:  Shelly L Gray; Sascha Dublin; Onchee Yu; Rod Walker; Melissa Anderson; Rebecca A Hubbard; Paul K Crane; Eric B Larson
Journal:  BMJ       Date:  2016-02-02
View more
  32 in total

1.  Trends in Insomnia Diagnosis and Treatment Among Medicare Beneficiaries, 2006-2013.

Authors:  Jennifer S Albrecht; Emerson M Wickwire; Aparna Vadlamani; Steven M Scharf; Sarah E Tom
Journal:  Am J Geriatr Psychiatry       Date:  2018-11-02       Impact factor: 4.105

Review 2.  Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.

Authors:  Brendan J Ng; David G Le Couteur; Sarah N Hilmer
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

Review 3.  Helpful approaches to older people experiencing mental health problems: a critical review of models of mental health care.

Authors:  Páll Biering
Journal:  Eur J Ageing       Date:  2018-11-03

4.  Patient-Oriented Policies To Reduce The Harmful Effects Of Medication On Seniors' Brain Function.

Authors:  Lori A Daiello; Cara Tannenbaum
Journal:  Public Policy Aging Rep       Date:  2018-09-28

5.  Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.

Authors:  Benjamin H Han; Scott E Sherman; Joseph J Palamar
Journal:  Prev Med       Date:  2019-02-11       Impact factor: 4.018

6.  An Examination of Prescribing Responsibilities between Psychiatrists and Primary Care Providers.

Authors:  Chiahung Chou; Cassidi C McDaniel; John David Abrams; Joel F Farley; Richard A Hansen
Journal:  Psychiatr Q       Date:  2021-06

Review 7.  Update on Medication Use Quality and Safety in Older Adults, 2017.

Authors:  Shelly L Gray; Zachary A Marcum; Kenneth E Schmader; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2018-11-13       Impact factor: 5.562

8.  Benzodiazepine Use and Misuse Among Adults in the United States.

Authors:  Donovan T Maust; Lewei A Lin; Frederic C Blow
Journal:  Psychiatr Serv       Date:  2018-12-17       Impact factor: 3.084

9.  Changes in Australian Early-Career General Practitioners' Benzodiazepine Prescribing: a Longitudinal Analysis.

Authors:  Parker Magin; Amanda Tapley; Adrian J Dunlop; Andrew Davey; Mieke van Driel; Elizabeth Holliday; Simon Morgan; Kim Henderson; Jean Ball; Nigel Catzikiris; Katie Mulquiney; Neil Spike; Rohan Kerr; Simon Holliday
Journal:  J Gen Intern Med       Date:  2018-07-23       Impact factor: 5.128

10.  Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries.

Authors:  Emerson M Wickwire; Sarah E Tom; Steven M Scharf; Aparna Vadlamani; Ilynn G Bulatao; Jennifer S Albrecht
Journal:  Sleep       Date:  2019-04-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.